Gilead’s Experimental Covid-19 Drug Scores Potential Tax Break

(Bloomberg) -- Gilead Sciences Inc.’s stock is little changed after an experimental treatment for Covid-19 secured a coveted regulatory designation that usually comes with tax breaks and a seven-ye...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.